VANGUARD GROUP INC - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 117 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,289,933
-39.5%
2,879,460
+8.6%
0.00%
-100.0%
Q2 2023$25,258,197
-11.1%
2,650,388
+2.6%
0.00%0.0%
Q1 2023$28,403,441
-24.2%
2,582,131
+2.0%
0.00%0.0%
Q4 2022$37,464,898
-13.0%
2,531,412
+12.4%
0.00%0.0%
Q3 2022$43,053,000
+12.3%
2,252,939
+25.3%
0.00%0.0%
Q2 2022$38,329,000
+30.0%
1,798,663
+17.5%
0.00%0.0%
Q1 2022$29,489,000
-6.1%
1,531,098
+1.1%
0.00%0.0%
Q4 2021$31,408,000
-11.9%
1,514,328
+1.5%
0.00%0.0%
Q3 2021$35,648,000
-12.6%
1,492,207
-0.1%
0.00%0.0%
Q2 2021$40,779,000
-7.8%
1,494,276
-2.3%
0.00%0.0%
Q1 2021$44,250,000
+44.7%
1,529,570
+40.7%
0.00%0.0%
Q4 2020$30,581,000
+21.8%
1,087,133
+26.8%
0.00%0.0%
Q3 2020$25,115,000
+120.0%
857,166
+127.0%
0.00%
Q2 2020$11,418,000
+118.4%
377,581
+115.3%
0.00%
Q1 2020$5,227,000175,4080.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$46,113,2723.06%
Pivotal bioVenture Partners Investment Advisor LLC 1,105,309$5,869,1912.34%
Bain Capital Life Sciences Investors, LLC 3,000,000$15,930,0001.78%
Sio Capital Management, LLC 635,969$3,376,9951.04%
Rubric Capital Management LP 5,034,530$26,733,3541.00%
Tejara Capital Ltd 309,179$1,641,7400.93%
AlphaCentric Advisors LLC 165,000$876,1500.50%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,135,227$6,028,0550.33%
Orbimed Advisors 1,914,479$10,165,8830.22%
Two Seas Capital LP 164,807$875,1250.18%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders